Stock Updates

A look at a High Market Cap Stock: Eli Lilly and Company, LLY

Eli Lilly and Company, LLY is in the exchange NYSE and its industry is Drug Manufacturers – Major in the sector of Healthcare. Based in USA, Eli Lilly and Company, LLY  has a market cap of 87760.63. Since its IPO date on the 6/1/1972, Eli Lilly and Company, LLY performance year to date is -4.17%. Today Eli Lilly and Company, LLY has gained 0.43%, with a current price of 79.66.

Ownership of the company is 11.70% for insider ownership while institutional ownership is 76.40%. The management of the company have seen the company have a payout ratio of 96.60%. Return of assets are at 6.50%, with return on investment at 9.50%.

In terms of debt levels and profit levels, Eli Lilly and Company, LLY is seeing a long-term debt/equity of 0.5. While Total debt/equity is 0.54. With a profit margin of 11.50%, this is combined with a gross margin of 74.40%, and operating margin of 13.40%. Eli Lilly and Company ability to meet debt levels, with a current ratio of 1.6, while the quick ratio is 1.1.

For the last year Eli Lilly and Company, LLY has seen a EPS growth of 1.60%. A performance for the year of -6.55%. The 52-week high is -12.48%, and the 52-week low is 18.14%. The average volume for Eli Lilly and Company, LLY is 3134821.

With a target price of 95.71, can Eli Lilly and Company, LLY reach this target? Looking at the value indicators of Eli Lilly and Company, LLY. Eli Lilly and Company has a P/E of 36.56 and a forward P/E of 19.9. Perhaps the more useful indicator than P/E, is PEG which has a value of 2.93. Eli Lilly and Company also has a P/S and a P/B of 4.35 and 5.63 respectively. For P/cash, Eli Lilly and Company has a value of 29.3, while it is *TBA for P/free cash flow.

At the current price of 79.66, Eli Lilly and Company has a dividend yield of 2.56%. We see a return on equity of 15.60%.

Looking more long-term Eli Lilly and Company, is projected to get an EPS growth for the next five years of 12.46%. In the short-term an EPS growth of 12.19% in the next year is forecasted. This is after a EPS growth of 1.60% for this year and for the last five years a -13.20% growth has been seen.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment